Kilkenny’s cycling club, Marble City Cyclers, in partnership with Glanbia, launched the fourth Tour de Kilkenny cycle challenge in aid of Barretstown, a charity which helps children with serious illnesses such as cancer, to regain their confidence and self-esteem through therapeutic recreation.
The cycle will take place on August 4, the Saturday of the August Bank Holiday weekend. Tour de Kilkenny has 40km, 70km, 110km and 160km route options to cater for cyclists of all abilities, allowing for a great day out with family, friends or work colleagues.
Marble City Cyclers’ Patrick Tobin, a Glanbia employee, said he was delighted with the participation and feedback from last year’s event:
“The event has grown in popularity every year and last year 670 cyclists took part. In the past three years, Tour de Kilkenny has raised €25,000 for Barretstown and we wish to raise even more much-needed funds for the charity this year. The more people that participate in and support the event, the bigger and better the event will be. We hope 2012’s Tour de Kilkenny to be our biggest yet.”
Glanbia has supported Tour de Kilkenny since its inception and it has become a key event for Glanbia to raise funds for and increase awareness of Barretstown. Barretstown has been Glanbia’s charity of choice since June 2008.
Speaking on behalf of Glanbia, Brian Phelan, Glanbia Group HR & Operations Director said: “Tour de Kilkenny is a tremendous event for the Kilkenny region one of Glanbia’s largest annual fundraising events for Barretstown, our chosen charity. Not only do many employees participate in the cycle itself but many other employees work as volunteers to help ensure that the day is a tremendous success. Glanbia has a proud tradition of supporting local community initiatives and we are delighted to be involved with the Tour de Kilkenny.”
Visit www.marblecitycyclers.com for more information or to enter online – entry fee is only €25/€20. All funds raised will go towards Barretstown, a charity rebuilding the lives of children who have suffered with cancer.